Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1981 1
1985 1
1987 4
1989 2
1991 2
1992 2
1993 2
1994 1
1995 4
1996 4
1997 2
1999 2
2000 6
2001 2
2002 3
2003 5
2004 4
2005 2
2006 3
2007 8
2008 6
2009 6
2010 5
2011 4
2012 10
2013 5
2014 7
2015 12
2016 13
2017 9
2018 20
2019 15
2020 13
2021 18
2022 15
2023 13
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Results by year

Filters applied: . Clear all
Page 1
Vitamin C in the Treatment of COVID-19.
Milani GP, Macchi M, Guz-Mark A. Milani GP, et al. Among authors: macchi m. Nutrients. 2021 Apr 1;13(4):1172. doi: 10.3390/nu13041172. Nutrients. 2021. PMID: 33916257 Free PMC article. Review.
Vitamin C is an essential nutrient that serves as antioxidant and plays a major role as co-factor and modulator of various pathways of the immune system. ...In many of the publications, data were incomplete, and in most clinical trials the results are still pending. No stu …
Vitamin C is an essential nutrient that serves as antioxidant and plays a major role as co-factor and modulator of various pathways o …
PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor.
Da Dalt L, Ruscica M, Bonacina F, Balzarotti G, Dhyani A, Di Cairano E, Baragetti A, Arnaboldi L, De Metrio S, Pellegatta F, Grigore L, Botta M, Macchi C, Uboldi P, Perego C, Catapano AL, Norata GD. Da Dalt L, et al. Among authors: macchi c. Eur Heart J. 2019 Jan 21;40(4):357-368. doi: 10.1093/eurheartj/ehy357. Eur Heart J. 2019. PMID: 29982592 Free article.
METHODS AND RESULTS: Pcsk9 KO, WT, Pcsk9/Ldlr double KO (DKO), Ldlr KO, albumin AlbCre+/Pcsk9LoxP/LoxP (liver-selective Pcsk9 knock-out mice), and AlbCre-/Pcsk9LoxP/LoxP mice were used. GTT, ITT, insulin and C-peptide plasma levels, pancreas morphology, and cholesterol acc …
METHODS AND RESULTS: Pcsk9 KO, WT, Pcsk9/Ldlr double KO (DKO), Ldlr KO, albumin AlbCre+/Pcsk9LoxP/LoxP (liver-selective Pcsk9 knock-out mice …
Appropriateness of statin prescription in the elderly.
Ruscica M, Macchi C, Pavanello C, Corsini A, Sahebkar A, Sirtori CR. Ruscica M, et al. Among authors: macchi c. Eur J Intern Med. 2018 Apr;50:33-40. doi: 10.1016/j.ejim.2017.12.011. Epub 2018 Jan 5. Eur J Intern Med. 2018. PMID: 29310996 Review.
The CTT meta-analysis calculated an absolute risk reduction of 0.6%/year per 38.7mg/dl reduction in LDL-C levels in patients aged >75years, that would translate into a number needed to treat of 167. ...
The CTT meta-analysis calculated an absolute risk reduction of 0.6%/year per 38.7mg/dl reduction in LDL-C levels in patients aged &gt …
A new dawn for managing dyslipidemias: The era of rna-based therapies.
Macchi C, Sirtori CR, Corsini A, Santos RD, Watts GF, Ruscica M. Macchi C, et al. Pharmacol Res. 2019 Dec;150:104413. doi: 10.1016/j.phrs.2019.104413. Epub 2019 Aug 23. Pharmacol Res. 2019. PMID: 31449975 Free article. Review.
The advantage of oligonucleotide-based treatments is that drug candidates are targeted at highly specific regions of RNA that code for proteins that in turn regulate lipid and lipoprotein metabolism. For LDL-C lowering, the use of inclisiran - a silencing RNA that inhibits …
The advantage of oligonucleotide-based treatments is that drug candidates are targeted at highly specific regions of RNA that code for prote …
Artificial cells drive neural differentiation.
Toparlak ÖD, Zasso J, Bridi S, Serra MD, Macchi P, Conti L, Baudet ML, Mansy SS. Toparlak ÖD, et al. Among authors: macchi p. Sci Adv. 2020 Sep 18;6(38):eabb4920. doi: 10.1126/sciadv.abb4920. Print 2020 Sep. Sci Adv. 2020. PMID: 32948587 Free PMC article.
Olfactory Nomenclature: An Orchestrated Effort to Clarify Terms and Definitions of Dysosmia, Anosmia, Hyposmia, Normosmia, Hyperosmia, Olfactory Intolerance, Parosmia, and Phantosmia/Olfactory Hallucination.
Hernandez AK, Landis BN, Altundag A, Fjaeldstad AW, Gane S, Holbrook EH, Huart C, Konstantinidis I, Lechner M, Macchi A, Portillo Mazal P, Miwa T, Philpott CM, Pinto JM, Poletti SC, Vodicka J, Welge-Luessen A, Whitcroft KL, Hummel T. Hernandez AK, et al. Among authors: macchi a. ORL J Otorhinolaryngol Relat Spec. 2023;85(6):312-320. doi: 10.1159/000530211. Epub 2023 Apr 14. ORL J Otorhinolaryngol Relat Spec. 2023. PMID: 37062268 Free PMC article. Review.
The Carotid Sinus Nerve-Structure, Function, and Clinical Implications.
Porzionato A, Macchi V, Stecco C, De Caro R. Porzionato A, et al. Among authors: macchi v. Anat Rec (Hoboken). 2019 Apr;302(4):575-587. doi: 10.1002/ar.23829. Epub 2018 May 2. Anat Rec (Hoboken). 2019. PMID: 29663677 Free article. Review.
In the carotid sinus, type I (dynamic) carotid baroreceptors have larger myelinated A-fibers; type II (tonic) baroreceptors show smaller A- and unmyelinated C-fibers. In the CB, afferent fibers are mainly stimulated by acetylcholine and ATP, released by type I cells. ...
In the carotid sinus, type I (dynamic) carotid baroreceptors have larger myelinated A-fibers; type II (tonic) baroreceptors show smaller A- …
Cholesteryl ester transfer protein: An enigmatic pharmacology - Antagonists and agonists.
Yamashita S, Ruscica M, Macchi C, Corsini A, Matsuzawa Y, Sirtori CR. Yamashita S, et al. Among authors: macchi c. Atherosclerosis. 2018 Nov;278:286-298. doi: 10.1016/j.atherosclerosis.2018.09.035. Epub 2018 Oct 1. Atherosclerosis. 2018. PMID: 30347344 Review.
Discovery of the CETP system has led to the development of agents interfering with CETP, thus elevating HDL-C and potentially preventing cardiovascular (CV) disease. Activation of CETP leads instead to reduced HDL-C levels, but also to an enhanced removal of CE from …
Discovery of the CETP system has led to the development of agents interfering with CETP, thus elevating HDL-C and potentially prevent …
Natriuretic peptides in the regulation of the hypothalamic-pituitary-adrenal axis.
Porzionato A, Macchi V, Rucinski M, Malendowicz LK, De Caro R. Porzionato A, et al. Among authors: macchi v. Int Rev Cell Mol Biol. 2010;280:1-39. doi: 10.1016/S1937-6448(10)80001-2. Epub 2010 Mar 18. Int Rev Cell Mol Biol. 2010. PMID: 20797680 Review.
Atrial (ANP), brain (BNP), and C-type (CNP) natriuretic peptides act by binding to three main subtypes of receptors, named NPR-A, -B, and -C. NPR-A and NPR-B are coupled with guanylate cyclase. Not only NPR-C is involved in removing natriuretic peptides from …
Atrial (ANP), brain (BNP), and C-type (CNP) natriuretic peptides act by binding to three main subtypes of receptors, named NPR-A, -B, …
219 results